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Abstract
In the US and other developed countries, food allergy is a growing epidemic in pediatric
populations with a substantial impact on health-related quality of life. As such, there are great
efforts underway to unravel the mechanisms of oral mucosal tolerance and to better define the
factors related to host and allergen exposure that contribute to the aberrant immune response
leading to sensitization and clinical food allergy. Although more research is needed to eventually
develop targeted treatment and prevention strategies, this review highlights our current
understanding of the pathogenesis of IgE-mediated food allergy.
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INTRODUCTION
Food allergy is an adverse health effect arising from a specific immune response that occurs
reproducibly on exposure to a given antigen [1]. It is a common, serious, and growing
problem in developed countries. Whereas the immune system of all individuals recognized
food antigens as foreign, patients with food allergy develop pathological immune responses
and can rapidly experience harmful adverse symptoms upon re-exposure. Determining the
precise prevalence of food allergy has been challenging since the most reliable indicator of
food allergy, the double-blind, placebo-controlled food challenge (DBPCFC), is too difficult
or time-consuming to employ in most prevalence studies. Self-reported survey data from the
Centers for Disease Control and Prevention indicate that the current prevalence of food
allergy in US children is approximately 4%, an increase of nearly 20% in the last decade [2].
A similar increase has been observed in methodologically rigorous studies from around the
world [3, 4], suggesting that the rise is not simply due to self-diagnosis or increased
recognition.
While food allergy is often considered to result from a failure in oral tolerance, spontaneous
clinical tolerance does develop in some food-allergic individuals. Although the process is
not entirely clear, resolution tends to occur in allergen-specific patterns. For example,
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allergy to egg, milk, wheat, and soy is generally outgrown, whereas most patients remain
allergic to peanut and tree nuts and must maintain life-long, strict elimination diets. Even so,
it is a common scenario for a child to outgrow an early milk or egg allergy but not a peanut
allergy [5]. Therefore, it appears that the pathophysiology of food allergy differs in antigen-
specific ways even within the same patient.
Due to an inability to predict the risk of anaphylaxis or determine the eliciting dose
threshold, avoidance remains the standard of care [1]; however, even in the most cautious
patients, accidental ingestions frequently occur and are often undertreated [5, 6]. The
inability to completely eliminate the possibility of anaphylaxis and the associated limitations
in everyday activities are great sources of uncertainty and stress for affected families [7].
Over time, health-related quality of life is seriously eroded, to a greater degree than seen in
other chronic diseases of childhood [8].
Consequently, great efforts are underway to better understand the mechanisms of oral
tolerance and conversely what factors cause them to go awry [9]. While many details remain
elusive, this review will cover our current knowledge of the pathogenesis of IgE-mediated
food allergy. To date, the majority of mechanistic evidence has been derived from animal
models, but we will review the evidence for similar phenomena in humans and the relevant
applications for clinical medicine where possible.
GI MUCOSAL IMMUNITY: OVERVIEW
The gastrointestinal tract, the largest immunologic organ in the body, is exposed to a
constant barrage of exogenous antigens on a daily basis [10]. The mucosal immune system
has evolved to inhibit responses to harmless antigens (e.g., commensal bacteria, food
protein) while maintaining the ability to mount a vigorous protective response when faced
with enteropathogens. Homeostasis between tolerance and immunity is therefore an active
immune process. This intricate balance can be modified by several factors in the intestine
and when disrupted can lead to a breach in oral tolerance and inappropriate allergic
sensitization to food proteins. Remarkably, only a single epithelial layer separates this
antigenic load from the lymphocytes, antigen presenting cells (APC), stromal cells and other
immune cells in the lamina propria, which together comprise the mucosal-associated
lymphoid tissue (MALT). Within the MALT, unique populations of dendritic cells (DCs)
interact with dietary antigens and determine the fate of the resulting adaptive response, i.e.,
immunity versus tolerance [11]. In this context, immune tolerance is defined as the antigen-
specific suppression of cellular or humoral immune responses. Normally, when the initial
antigen exposure occurs through the GI tract, a robust T cell-mediated suppression develops
called oral tolerance [12]; however, in 4–6% of children, this mechanism appears to fail,
leading to sensitization and elicitation. We will first consider several factors related to the
host and the allergen exposure that may play a role in determining the nature of the immune
response.
THE INTRINSIC PHYSICAL PROPERTIES OF FOOD ALLERGENS
Of the 12,000+ food protein families in existence, a relatively small number cause the
majority of food allergies [5]. This fact suggests that the main food allergens – milk, egg,
wheat, soy, peanut, tree nuts, fish, and crustacea – though diverse in origin, share common
functional characteristics that confer allergenicity: (1) small molecular weight, (2) an
abundant source of the relevant allergen, (3) glycosylation residues, (4) water solubility, and
(5) resistance to heat and digestion. These properties are unique to food allergens, which
unlike inhaled or contact allergens, must pass through the harsh environment of the digestive
system. Following ingestion, processing of dietary proteins by salivary and gastric enzymes
and gastric acid results in reduced immunogenicity, likely by the destruction of
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conformational epitopes. However, proteins with the above physicochemical properties
resist this processing and have allergenic potential upon reaching the small intestine. Factors
that disrupt normal digestion such as co-administration of antacids have been shown in
animal models to result in a breakdown in oral tolerance induction [13].
Because food antigens are non-self proteins, all normal individuals will mount an immune
response [14, 15]. However, once putative allergens survive the digestion process relatively
intact, they must initiate a TH2 response in order to result in IgE production and disease
expression. While most of the focus in understanding the cellular and molecular basis of
allergenicity has been on T and B cell epitopes, there is no compelling evidence for the
presence of common structural characteristics [16]. Consequently, there has been renewed
interest in studying the innate immune system and its activation by allergens [17]. In
particular, recent studies have highlighted the emerging importance of the carbohydrate
residues, which decorate glycosylated proteins and can act as adjuvants by influencing
immunogenicity and TH2 polarization [18]. This is not entirely surprising, given that the
mucosal IgE system evolved to defend the host from intestinal metazoan parasites, which
themselves are heavily glycosylated. Other potentially important features of food allergens
include lipid binding as well as higher order macromolecular structures that may promote
aggregation and influence transepithelial transport [19].
While some common food allergens may possess self-adjuvant activity promoting
sensitization, other foods possess immunomodulatory effects to suppress sensitization.
Isoflavones present in soy have recently been shown to hinder allergic sensitization in
human DCs as well as protect against peanut allergy in a murine model [20]. Zhou and
colleagues [21] demonstrated that binding of sugar-modified antigen to the innate immune
receptor SIGN-R1 (murine homolog to human DC-SIGN) could reduce the anaphylactic
response to food allergen by inducing DCs to release IL-10 and to generate T-regulatory
type 1 cells (Tr1). Thus, the specific modulatory effect of a given food antigen on innate
immune cells could explain its allergenic potency. For example, peanut and soy proteins
share extensive amino acid homology yet confer differing prevalence rates and symptom
severity.
ONSET OF SENSITIZATION: GENETICS, TIMING, AND ENVIRONMENT
Genetics plays a clear role in mouse models in which certain strains have exaggerated TH2
bias whereas others resist sensitization [22]. Likewise, familial aggregation in food allergy
[23], high concordance rates of peanut allergy among monozygotic twins [24], and certain
racial/ethnic predilections [25] suggest that genetics plays a significant role in humans as
well. Few genome-wide association studies of food allergy have been performed, and
although polymorphisms in genes associated with food allergy have been found in single
studies, the results have not been replicated in independent populations [26, 27]. Candidate
gene approaches have been largely unsuccessful, with the exception being one case-control
study suggesting increased risk of peanut allergy in 71 UK subjects with loss-of-function
filaggrin mutations [28]. While genetic susceptibility undoubtedly contributes to the onset of
disease, the rise in prevalence is more rapid than genetics can explain, thus drawing
attention to environmental factors. Increasing interest in epigenetic modifications may
elucidate an important role for heritable gene-environment interactions in food allergy
pathogenesis [29].
Although food sensitization is often an early life event [30], it remains controversial whether
allergic priming could occur in humans in utero [31–33]. Furthermore, manipulation of the
maternal diet during pregnancy and/or lactation has demonstrated little protective effect on
the development of food allergy [34, 35]. In mouse models, high-dose exposure to antigen in
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early life, even a single isolated dose, can produce lymphocyte anergy, whereas repeated,
low-dose exposure induces tolerance through T-regulatory cell (Treg) development [36].
Emerging evidence in human disease suggests that exposure to the proper dose of antigen
during this critical period in early life is important for the shaping of the appropriate immune
response to foods. Several epidemiologic studies have implicated delayed weaning patterns
in the increased prevalence of peanut allergy [37–39]. Similarly there is evidence that
delayed introduction of cereals is associated with a higher risk of wheat allergy [40].
European and American feeding guidelines have recently been revised to reflect the position
that insufficient evidence exists to support delayed weaning as a preventative strategy [1, 41,
42]. However, early introduction is not necessarily better, since mature immune regulation
may require time [43]. Cow’s milk is typically the first potentially allergenic exposure and
yet is the most common food to which US children are allergic [5]. In addition, maternal
peanut consumption during breastfeeding, but not pregnancy, was associated with peanut
sensitization [44]. Defining the most appropriate time and dose for tolerance induction in
humans is a great research need. Interventional studies are underway to investigate the
importance of early life oral exposure in tolerance development.
The modern rise in food allergy has coincided with a concurrent upsurge in vitamin D
deficiency (VDD). A hormone that binds nuclear elements and is known to affect both
innate and adaptive immunity, VDD has already been linked to the development of atopic
dermatitis [45] and recurrent wheeze [46], leading to the hypothesis that deficiency of this
key environmental factor may also play a role in the pathogenesis of food allergy [47].
Supporting evidence includes the influential role of 1,25 (OH)2D in Treg development [48],
microbiome diversity [49], and mucosal barrier maintenance and repair [50]. Recently, data
from the National Health and Nutrition Examination Survey revealed that VDD was
associated with higher levels of IgE sensitization to peanut and select aeroallergens in
children and adolescents, but not adults [51]. While too common to be individually
responsible, VDD is another plausible contributing factor to the increasing prevalence of
food allergy.
ROUTE OF EXPOSURE
The coinciding increase in food allergy with dietary guidelines to delay introduction of
allergenic foods has led to the hypothesis that sensitization may occur through non-oral
routes. Given the high concurrence rates of food allergy among patients with atopic
dermatitis, the skin is of particular interest; as previously noted, filaggrin mutations are
thought to confer enhanced risk for peanut allergy. Household peanut consumption has been
linked to an increased risk of peanut sensitization in children, independent of maternal
peanut intake [38]. In addition, many children experience allergic reactions after their first
known oral ingestion [52], suggesting sensitization through previous occult exposure. These
observations suggest that oral exposure is tolerogenic by default, while exposure through
other routes preferentially induces sensitization. Reinforcing this concept was the finding
that UK children with positive oral food challenges to peanut were significantly more likely
to have used eczema creams containing peanut oil than atopic or normal controls [31].
Studies of epicutaneous sensitization in murine models are conflicting regarding whether the
skin is intrinsically pro-allergenic [53]. Interestingly, epicutaneous immunotherapy is being
developed as an experimental treatment for food allergy [54, 55]. In the sections that follow,
we will review the mechanisms in the gut that may determine whether a food exposure
results in allergy or tolerance.
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MICROBIOME: THE GOOD WITH THE BAD
A critical influence on the mucosal immune response is the microbial stimulation provided
by the enteric flora, which by adulthood number approximately 100 trillion in the large
intestine [56]. Within hours of birth, bacteria colonize the neonatal GI tract and begin
interacting with the MALT; this probably represents the primary stimulus for proper
postnatal immune development, since germ-free mice have disorganized and poorly
developed mucosal and secondary lymphoid structures. In the absence of a microbial flora,
these animals have impaired antibody responses and do not develop oral tolerance [57].
More recently, a birth cohort study following high-risk children through 6 years of age
demonstrated that the bacterial diversity of intestinal flora was inversely associated with the
risk of allergic sensitization to foods and aeroallergens, peripheral blood eosinophilia, and
allergic rhinitis [58]. However, reduced bacterial diversity was not associated with an
increased risk of asthma or atopic dermatitis in the first 6 years of life. Other studies have
identified specific differences in the flora of allergic and nonallergic children [59, 60]. This
suggests that although intestinal microbial colonization is required for proper immune
development, certain microbes may play a significant role in skewing the immune response
toward allergic sensitization, possibly by suppressing the general biodiversity and creating
an environment that enhances the development of allergic disease. Interestingly, a group of
investigators has recently linked a decline in environmental biodiversity with a decline in the
biodiversity of skin flora in atopic individuals [61], possibly explaining why urban
populations are disproportionately affected by allergic disease.
The critical information provided by the microbiome is interpreted through signals from
innate pattern recognition receptors (PRR) such as toll-like receptors (TLRs), which play an
important role in intestinal homeostasis [62], in the genesis of Tregs [63] and on the
outcome of allergic disease [64]. Recently, differences in TLR-mediated microbial
responses at birth and over time were found between allergic and nonallergic children, with
the latter demonstrating age-related increased responsiveness to these recognition pathways
[65]. Additionally, investigators have identified specific microbial products (i.e.,
polysaccharide A from Bacteroides fragilis) that interact with TLRs and promote
downstream induction of Tregs, modulating intestinal inflammation in mouse models of
experimental colitis [63]. This differs from the general consensus that TLR4 pathways are
both necessary and sufficient for the development of allergen-driven TH2 immune responses
in the airway [66, 67]. The intricacy of the innate signaling pathways has made identifying
the specific microbial signal(s) that is/are most important in determining the immune
response to food antigen in humans particularly challenging. This is evidenced by the
overall disappointing results of probiotic trials on the prevention and treatment of allergic
disease [68]. However, new deep-sequencing technologies that focus on the unique 16s
ribosomal subunit of bacterial RNA rather than culture-based methods are allowing
investigators to identify previously unknown organisms [69].
MUCOSAL BARRIER: FIRST LINE OF DEFENSE
The “first-line” features of mucosal defense include mucin oligosaccharides and
antimicrobial peptides that serve to prevent luminal antigens from interacting with the
MALT entirely. Secretory IgA also binds to luminal antigens preventing absorption (i.e.,
“immune exclusion”). However, its specific importance has been controversial since it
appears that cellular mechanisms can compensate for impaired immune exclusion [70, 71].
If a potential allergen penetrates these initial physical factors, the intestinal epithelium itself
acts as a barrier to sequester luminal antigens from the MALT, and leakiness of this barrier
has been postulated to result in allergic sensitization. Structural integrity of the intestinal
epithelium is conferred by adherens junctions and tight junctions, but it may take years for
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complete developmental maturation of the gut barrier in healthy children [72]. In mice, the
permeability of this barrier is further influenced by environmental exposures that result in
changes in gene expression and phosphorylation of tight junction proteins such as occludins,
claudins, and JAM-ZO1 proteins, which in turn are associated with changes in intestinal
mast cells and allergic sensitization [73, 74].
Interestingly, examination of the lactulose/mannitol ratio in urine revealed that food-allergic
infants had increased intestinal permeability when compared to healthy children [75]. Even
following a minimum 6-month period of allergen avoidance, the intestinal permeability in
food-allergic children remained increased. Further evidence linking intestinal epithelial
barrier dysfunction and food allergy comes from studies in patients who developed food
allergy after solid-organ transplantation while taking calcineurin inhibitors. While initially
assumed to result from the transfer of sensitized donor lymphocytes, it is now theorized that
medication-induced decreases in cellular ATP altered the integrity of junctional complexes,
resulting in increased intestinal permeability [76].
Increasing evidence suggests that the mucosal epithelium is more than simply an inert
physical barrier. Epithelial cells express MHC class II molecules and thus may act as
nonprofessional APCs that lack conventional co-stimulatory molecules, thus favoring
anergy or tolerance [77]. In addition, factors derived from the gut epithelium are generally
believed to condition the DCs in the stroma, dampening immune responses and promoting
gut homeostasis [78]. One such factor is retinoic acid (RA), which in combination with
TGF-β is essential for the differentiation of Treg-inducing DCs [79]. Another factor
constitutively expressed by the gut epithelium is thymic stromal lymphopoetin (TSLP).
TSLP is an IL-7 like cytokine that can activate expression of OX40L on DCs and drive TH2
differentiation. Although TSLP has demonstrated a regulatory role in the gut by limiting
deleterious TH1 and TH17 inflammation in models of helminth infection and colitis [80],
other studies have shown that TSLP amplifies TH2 responses directly from CD4+T cells and
is required for allergic inflammation although not for sensitization or tolerance [81].
Furthermore, a recent study illustrated that TSLP promotes systemic basophilia, resulting in
increased TH2 cytokines and IgE [82].
INNATE IMMUNITY: DENDRITIC CELLS SET THE STAGE
If food proteins survive digestion and evade luminal defenses, they will be detected by
APCs in the MALT in the context of signals provided by the commensal flora. In this way, a
complex interplay of all aforementioned factors (i.e., antigen character, dose, timing, and
innate immune stimulation) will determine the immune response to an ingested food protein
through the same final common pathway: by directly or indirectly influencing the APC.
Mucosal DCs are probably the most critical determinant of allergic sensitization versus
tolerance in naïve individuals, largely because of their location and their capacity to receive
and interpret environmental signals, which lead to a specific immune response. These DCs
can encounter ingested antigen in one of three ways: by extending dendrites through the
paracellular space between epithelial cells to sample luminal contents, by directly interacting
with the epithelial cells, and by taking up antigen in Peyer’s patch, specialized lymphoid
tissue that is immediately adjacent to microfold cells [83]. The properties of the antigen
itself − particulate versus soluble − to a certain extent determine the route of exposure.
One of the more recent advancements fostering our understanding of oral tolerance is the
characterization of two critically important and developmentally distinct subsets of intestinal
DCs that can be discriminated by the cell surface expression of either CD103 or CX3CR1
[84,85]. Of these two populations, only CD103+DCs are able to migrate from the lamina
propria to the mesenteric lymph node (MLN); thus, the CX3CR1+ cells (which are CD103−)
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are more appropriately categorized as intestinal macrophages. After acquiring antigen,
CD103+DCs migrate from the lamina propria to the MLN in a CCR7-dependent manner
(Figure 1) [86]. These specialized DCs express the enzyme retinaldehyde dehydrogenase 2,
which converts the vitamin A metabolite retinal to RA. In the presence of TGF-β, which is
also produced by CD103+DC, RA can promote the differentiation of naïve T cells within the
MLN into Foxp3-expressing Tregs. Moreover, the CD103+DC uses RA to imprint naïve T
cells with the gut homing markers integrin α4β7 and chemokine receptor CCR9. Further
contributing to their tolerogenic capabilities, CD103+DCs also express the enzyme
indoleamine 2,3 dioxygenase (IDO), which serves to inhibit the generation of T-effector
cells by metabolizing tryptophan and producing toxic byproducts [87]. Inhibition of IDO
abrogates the development of inducible Foxp3+Tregs in vitro and prevents the development
of oral tolerance in vivo [88]. This finding along with defective oral tolerance in CCR7-
deficient mice suggests that CD103+DCs are critical to the induction of oral tolerance.
Recently, two studies [89, 90] definitively established that α4β7, CCR9 expressing
Foxp3+Tregs are required for oral tolerance. Using DEREG mice that selectively express the
diphtheria toxin receptor on Foxp3+ cells, investigators demonstrated the reversal of oral
tolerance following ablation of Foxp3+T cells with diphtheria toxin after antigen feeding.
While CD103+DCs are essential to oral tolerance induction, intestinal CX3CR1+
macrophages are necessary to sustain local tolerance induction [89]. This subset of DC
expands FoxP3+Tregs in the lamina propria, produces IL-10, and clears bacteria that breach
the epithelial barrier. Exploiting the inherently tolerogenic characteristics of CD103+DC –
for example, by targeting delivery of a specific antigen, could represent a potential treatment
modality in the future, although a much greater understanding of their biology is first
needed.
The acquisition of CD103+DC’s unique tolerogenic properties likely requires a specific
milieu of local conditioning factors provided by intestinal epithelial cells (IECs), commensal
bacteria, and dietary constituents. The differentiation of CD103+DC depends upon RA and
TGF-β produced by the IECs [79]. Commensal bacteria such as Bacteroides and
Bifidobacteria strains are capable of directly inducing monocyte-derived DC to acquire a
tolerogenic phenotype [56]. Signaling through certain members of the CLR family (e.g.,
dectin-1, SIGN-R1) upon recognition of microbial glycans also leads to induction of oral
tolerance [21]. Depletion of vitamin A and tryptophan from the diet (the only source for
these nutrients in mammals) hinders the tolerogenic effect of CD103+DC by hampering their
ability to generate Tregs and imprint gut homing receptors on lymphocytes [87].
Exactly what factors skew the CD103+DC toward a non-tolerogenic phenotype or perhaps
propagate a different proallergenic DC subset are not entirely clear. However, the potential
pathways involved have been highlighted by experiments using adjuvants to orally sensitize
mice [53]. Feeding of cholera toxin (CT) alters the migration of CD103+DC from the lamina
propria to the MLN and enhances their maturation, leading to enhanced T cell priming [91].
Upregulation of OX40L in the CD103+DC was responsible for an increase in IL-4 and IL-13
by T-effector cells and for the sensitizing capabilities of CT [92]. Within the lamina propria,
allergic sensitization was also associated with an increase in CD11b+DC and relative
decrease in the CD103+DC subset [93], indicating that the phenotype of intestinal DC
determines the immune response to antigen. While CT is unlikely to play a role in human
food allergy, Staphylococcal enterotoxin B (SEB) is a toxin produced by some strains of
Staphylococcus aureus. SEB is frequently found as a contaminant in the food supply and
frequently produced by colonizing strains present on the skin of atopic dermatitis patients
[94]. As an oral adjuvant in mouse models of sensitization, SEB has exhibited an ability to
increase TH2 cytokine expression and decrease TGF-β and Foxp3 expression in vitro [95].
Furthermore, SEB acts directly on DCs to upregulate TIM-4 expression, which drives TH2
cytokine production in T-effector cells [96]. TIM-4 expressed on DCs and its ligand TIM-1
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on T cells have been shown to be critical regulators of TH2 differentiation in humans and
mice [96, 97]. Similar to CT, TSLP-stimulated DCs act through OX40L to induce TH2 cells
and thus may serve as a natural adjuvant when expressed by IECs. Determining additional
environmental factors that are capable of modulating molecules such as OX-40L and TIM-4
on gastrointestinal DCs may identify factors potentially responsible for the steep increase in
the incidence of food allergy in recent years.
If the DC-food allergen interaction fails to induce tolerance, the ensuing immune response
proceeds through two phases: allergic sensitization and elicitation. Allergic sensitization
involves T cell priming after DC activation, and the resultant T-helper-2 (TH2) response is
characterized by the production of interleukin-4 (IL-4), IL-5, and IL-13 from CD4+T cells.
This TH2 response leads to B-cell IgE production, and this IgE binds to its high-affinity
receptor on the surface of mast cells in the skin, gut, and respiratory and cardiovascular
systems, arming them for reactivity upon re-exposure to allergen. The elicitation of classic
allergic symptoms occurs within minutes after allergen exposure, when IgE-bound mast
cells recognize the allergen and become activated [14].
CONCLUSIONS
Although food allergy affects 12 million Americans, it is remarkable that it is not more
common considering the complexities of the mucosal immune system. Robust immunologic
mechanisms involving both humoral and cell-mediated responses have evolved to maintain a
homeostatic environment amidst the literally billions of antigens within the intestine. In
order to incite the allergic cascade, an ingested protein must circumvent this tolerogenic
system. Several interrelated factors such as genetic susceptibility and age of the host;
antigen timing, dose, and route of exposure; enteric microbiome; and dietary constituents
can influence the immune response toward oral tolerance or sensitization and clinical food
allergy. More insight into these complex interactions will be essential to developing targeted
treatments for food allergy and eventually primary prevention strategies.
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After taking up antigen in the lamina propria, CD103+ dendritic cells (DCs) migrate to the
mesenteric lymph node. CD103+DCs present antigen to naïve T cells that are induced to
differentiate into FoxP3-expressing T-regulatory cells (Tregs) and imprinted with α4β7 and
CCR9. After homing back to the gut, CX3CR1+ (CD103−) cells secrete IL-10 to allow for
local expansion of Tregs and induction of oral tolerance. (Adapted from Hadis et al. [89•];
copyright 2011, Elsevier; with permission.)
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